Monoclonal antibodies (MAbs) against the rubella virion were used to locate epitopes involved in hemagglutination and neutralization. The MAbs exhibiting high-level hemagglutination-inhibiting activity were shown by Western blot analysis to be specific for the El polypeptide; this is consistent with the presence of the hemagglutinin on the El polypeptide. Some of the El-specific MAbs also neutralized viral infectivity. However, hemagglutination-inhibiting activity and neutralizing activity did not always correlate. Three distinct functional epitopes were identified on the El polypeptide by competition analyses: (i) one which reacted with MAbs with high-level hemagglutination-inhibiting activity and with neutralizing activity, (ii) one which reacted with MAbs with low-level hemagglutination-inhibiting activity and with neutralizing activity, and (iii) one which reacted with MAbs with only hemagglutination-inhibiting activity. A MAb specific for the E2 polypeptide exhibited neutralizing activity. This E2-specific MAb and two El-specific MAbs with neutralizing activity were capable of precipitating intact virus which indicates that at least three epitopes involved in neutralization are accessible on the surface of the virion.
Rubella virus (RV) is the sole member of the genus
Rubivirus and is in the family Togaviridae; it was isolated and propagated in cell culture in 1961. RV replication and protein synthesis are much like replication and protein synthesis in the alphaviruses in that the structural protein genes are located in the 3' portion of the 40S genomic RNA, and the structural proteins are translated from a 24S messenger RNA (13) . The virion consists of three major structural polypeptides, designated El, E2, and C; El and E2 are glycosylated. The E2 glycopolypeptide migrates as a diffuse band in polyacrylamide gels. Oker-Blom et al. (12) detected two bands, designated E2a (molecular weight, 47,000) and E2b (molecular weight, 42,000). Since tryptic maps of E2a and E2b were identical, they proposed that the molecular weight difference resulted from heterogeneous glycosylation of the same gene product. These data were supported by intrinsic labeling experiments with [3H]mannose which showed that mannose was more efficiently incorporated into E2b than into E2a. Waxham and Wolinsky (27) showed by isoelectric focusing that the E2 polypeptide can be broken into a broad range of molecules that span the molecular weight range from E2a to E2b. They also attributed this heterogeneity to posttranslational modification of the same gene product. The two glycopolypeptides, El (molecular weight, 63,000) and E2, compose the stubby spikelike projections on the virion envelope (15, 24) . The capsid is constructed from the nonglycosylated C polypeptide (molecular weight, 30,000).
Similar to those of other enveloped viruses, the RV glycoproteins appear to contain antigens responsible for the elicitation of immunity in the host (2, 19) . The El glycopolypeptide, which was associated also with the hemagglutinin (HA) (8, 26) , was associated with the binding of hemagglutination-inhibiting (HI) antibody (3, 16, 26, 28) and hemolysis-inhibiting antibody (27) . The E2 glycopolypeptide * Corresponding author.
contains strain-specific antigens (3) and was linked indirectly with neutralization (NT) (8) .
Since it has proven difficult to isolate the protein subunits from RV without destroying their biological activity (23) , the polypeptide constituents and epitope locations of the antigens responsible for NT have not been characterized, and it has not been determined whether HI and NT antibody functions correlate. Our research located and characterized antigens involved in the binding of HI and NT antibodies and determined whether HI antibody also neutralizes viral infectivity. To accomplish this, a panel of hybridomas which secreted monoclonal antibodies (MAbs) specific for RV was constructed. MAbs were isolated which exhibited HI or NT activity or both, and these MAbs were found to be specific for the El polypeptide. A MAb was also isolated which was specific for the E2 polypeptide and exhibited NT activity.
MATERIALS AND METHODS Cells and virus. RV strain HPV-77 was plaque purified three times in Vero cells. The virus was purified from the culture fluid of infected Vero cells by a modification of the procedure described by Gravell et al. (6) .
Construction of hybridomas. BALB/c mice were each immunized intraperitoneally with 100 ,ug of purified RV. After 30 days, each mouse received an intraperitoneal booster injection of 100 ,ug of virus, and the spleen cells were harvested for hybridoma production after an additional 3 days.
For production of hybridomas, the spleen cells were fused with SP2/0-Agl4 murine myeloma cells (20) at a ratio of 3:1 in 35% (wt/vol) polyethylene glycol by the method of Gefter et al. (5) . After an overnight incubation at 37°C, the cells were suspended in medium containing hypoxanthine (0.027 mg/ml), aminopterin (0.00036 mg/ml), and thymidine (0.015 mglml). Screening of the culture fluids was done 2 to 3 weeks later by a modification of the enzyme-linked immunosorbent assay (ELISA) described by Gravell et al. (6) with purified 894 GREEN AND DORSETT RV immobilized on polyvinyl microtiter plates (Costar) and rabbit anti-mouse immunoglobulins conjugated with alkaline phosphatase (Sigma Chemical Co.) at a 1:1,000 dilution. Positive colonies were expanded and cloned twice in soft agar.
Production of ascites fluids and determination of MAb isotypes. Ascites preparations containing high titers of MAbs were produced by intraperitoneal injection of approximately 5 x 106 hybridoma cells into each BALB/c mouse primed 3 weeks before with 1 ml of pristane (Sigma). Ascites was also prepared with hybridoma cells which secreted immunoglobulins nonspecific for RV for use as negative ascites controls. The ascites fluids were collected after 1 to 2 weeks, clarified by low-speed centrifugation, and stored at -70°C. MAb isotypes were determined by ELISA with class-and subclass-specific antisera by using the MonoAb-ID EIA Kit (Zymed Laboratories).
Determination of protein specificity of MAbs. The polypeptide specificity of each MAb was determined by using a modification of the Western blot technique described by Burnett (1) . Purified RV was disrupted in sample buffer containing 0.05% sodium dodecyl sulfate (SDS) in the presence or absence of 2-mercaptoethanol as a reducing agent, and the solubilized polypeptides were electrophoresed through an 8.8% polyacrylamide gel at 20 mA for 5 h at 4°C using the buffer system of Laemmli (9 Fig. 1 . These five MAbs (lanes 2 to 5) reacted only with nonreduced El antigens and with the glycoprotein dimers that contain El. Lane 1, developed with mouse hyperimmune serum, shows the three RV structural proteins and the two glycoprotein dimers, El:El and El:E2 (8, 26) . Under the nonreducing conditions used, the capsid protein migrated as a disulfide-linked dimer of the C polypeptide (12, 27) .
Immunoprecipitations. Immunoprecipitations of purified intact RV or SDS-disrupted, nonreduced RV were done to determine whether the El-or E2-specific MAbs reacted with antigens exposed on the external surface of the virion (Fig.  2) . Purified RV (lane 1) was used as a marker for the locations of the precipitated polypeptides. Under the reducing conditions used, there was an apparent decrease in the amount of the glycoprotein dimers, and the C protein migrated as the monomeric C polypeptide. The El-specific MAbs 1-6 and 2-6 precipitated whole virus (lanes 3 and 5, respectively) as indicated by the presence of all three structural polypeptides in the precipitate. Functional activities of MAbs. Western blot analysis showed the polypeptide specificity of each of the MAbs and revealed that MAbs specific for each of the three structural polypeptides of RV had been isolated. Immunoprecipitations indicated the location of some of these epitopes within the virion. To determine the location of the sites for hemagglutination and NT, each of the MAbs was tested for HI and NT activities ( Table 1) . Some of the El-specific MAbs exhibited high-level HI activity (MAbs 2-6, 2-42, 3-8, 2-12, and 2-13), whereas others exhibited comparatively low-level activity (MAbs 1-6 and 3-7) or had no activity (MAb 2-34). Although the ELISA titer for each of the MAbs was approximately the same, there was at least a 3-log difference in the HI titers of the high-level and low-level HI MAbs. This variation in HI activity implies that different sites on the El protein bind HI antibody since some HI MAbs appear to function in this activity more effectively than others. The El MAbs exhibiting high-level HI activity reacted on Western blots only with nonreduced El antigens (Fig. 1) , whereas those exhibiting low-level activity reacted with reduced or nonreduced El antigens (data not shown). The E2-specific MAb (26-24) did not exhibit HI activity. However, at low dilutions (1:8 and 1:16) it did cause an aberrant pattern in the virus hemagglutination reaction. To determine whether the HI and NT activities correlated, the MAbs were tested for NT activity in an in vitro plaque reduction assay. The results of typical NT assays using a MAb with NT activity (MAb 2-6) and a MAb without NT activity (MAb 2-13) are shown in Fig. 3 overlay containing medium, 2% fetal bovine serum, and antibiotics was added to the monolayers as described in the text; the monolayers were then incubated in a humidified air-CO2 atmosphere for 6 days. The monolayers were fixed with Formalin and stained with crystal violet, and the number of plaques at each dilution of antibody was counted. MAb 2-6 (0-0) is representative of the El-specific MAbs which demonstrated in vitro NT activity by reducing the number of plaques, whereas MAb 2-13 (0-0) is representative of the Elspecific MAbs which did not exhibit in vitro NT activity. may or may not correlate and that the El polypeptide contains epitopes which react with antibodies exhibiting HI or NT activity or both. The E2 polypeptide contains an epitope which reacted with an antibody exhibiting only NT activity. MAbs specific for the C polypeptide did not exhibit HI or NT activity.
Identification of functional epitopes on the El polypeptide by competition analysis. Since HI and NT activities of the El-specific MAbs did not always correlate, it appeared that the two activities involved different epitopes on the El polypeptide. To confirm this, the El-specific MAbs were analyzed by competitive binding assays (Table 2) . MAbs 2-6, 2-42, and 3-8, exhibiting NT activity and high-level HI activity, competed with one another. MAb 3-7, which exhibited NT activity and low-level HI activity, did not compete with any of the other MAbs, whereas MAb 1-6, which was similar to MAb 3-7 in activity, did compete to some extent with all of the El-specific MAbs. MAb 2-13, which exhibited high-level HI activity but no NT activity, competed only with itself. MAb 2-12, which showed activities similar to MAb 2-13, competed with 2-13 (data not shown); however, testing for the reciprocal competition was not done. MAb 2-34, which did not exhibit HI or NT activity, did not compete with any of the other MAbs (data not shown). These data indicate that at least three epitopes exist on the El polypeptide which bind antibodies with different functional HI and NT activities.
DISCUSSION
The envelope of RV contains spike proteins composed of two closely associated glycopolypeptides, El and E2, which are involved in virus-host interactions. However, the specific role of each of these envelope glycopolypeptides in the host immune response to RV have not been fully characterized. In this study, epitopes that are involved in hemagglutination and NT were identified and characterized by reactions with MAbs. These data can be compared with previous data obtained with polyspecific immune sera to gain further insight into the structure and functions of the envelope glycoproteins.
Similar to other investigators, we found that MAbs exhibiting HI activity were specific for the El glycopolypeptide, which confirms its role in hemagglutination. A MAb specific for the E2 protein did not exhibit HI activity, although low dilutions of this antibody appeared to cause a partial inhibition of hemagglutination. This may have been due to nonspecific inhibitors of the HA in the ascites fluid, although the ascites had been pretreated with CaC12 and dextran sulfate and negative ascites controls did not exhibit this activity. An HI antibody titer following RV infection persists for many years and is used to monitor immunity to rubella. However, cases have been reported in which HI-positive individuals were reinfected with the virus, resulting in a congenital rubella syndrome (10, 14) . Trudel reported the isolation of a MAb with low NT activity but no HI activity (22) . These data imply that different epitopes elicit these antibody functions, but they do not indicate the polypeptide location(s) of the NT epitopes or whether HI antibody could exhibit an NT function. Recently, Waxham and Wolinsky (28) 
